New York, New York--(Newsfile Corp. - November 20, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America's Car-Mart may have issued materially misleading business information to the investing public. SO WHAT: If you purchased America's Car-Mart securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

DoorDash stands out as a resilient growth story amid restaurant sector weakness, despite its recent 30% stock correction. DASH's unique partnerships, promotions, and ecosystem are insulating it from the consumer spending slowdown impacting restaurant chains. Concerns over increased 2026 investments are overblown, as DASH's strong free cash flow and new initiatives like DoorDash for Business drive growth.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Freeport-McMoran To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options

Philadelphia, Pennsylvania--(Newsfile Corp. - November 20, 2025) - Grabar Law Office is investigating claims on behalf of Inspire Medical Systems, Inc. (NYSE: INSP) shareholders. The investigation concerns whether certain officers of Inspire Medical have breached their fiduciary duties owed to the company.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their Options

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CarMax To Contact Him Directly To Discuss Their Options

CUMMING, Ga., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced it has released new home designs at its Westover community in Cumming, Georgia. The three new home designs feature thoughtfully designed floor plans with first-floor primary bedrooms and elegant architectural details, providing home shoppers with an exceptional combination of comfort and sophistication. Prices for new homes in Westover start from the mid-$700,000s.

Yesterday, after the stock market's closing bell, Nvidia Corporation (Nasdaq: NVDA) reported its Q3 2026 financials.

SAN DIEGO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Perrigo Company plc (NYSE: PRGO) securities between February 27, 2024 and November 4, 2025. Perrigo provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally.

SAN FRANCISCO--(BUSINESS WIRE)--To celebrate International Fraud Awareness Week, Visa (NYSE: V) today released its Fall 2025 Biannual Threats Report, revealing five forces that are transforming the global payments security landscape. The report, produced by Visa's Payment Ecosystem Risk and Control (PERC) team, draws on intelligence from Visa's global network to identify how criminal operations are evolving with unprecedented speed, scale, and sophistication. "The payments ecosystem is experien.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Avantor To Contact Him Directly To Discuss Their Options

NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public.

Tarsus Pharmaceuticals, Inc. is upgraded to Strong Buy with a 12-month price target of $100/share, driven by Xdemvy's rapid commercialization. Xdemvy remains the only approved treatment for Demodex blepharitis, with accelerating sales growth and significant untapped patient population in the U.S. TARS is poised for further upside from global expansion, robust pipeline, and an earnings inflection expected in 2026 as revenue growth achieves profitability.

A Media Snippet accompanying this announcement is available by clicking on this link.

UFP Industries is upgraded to a soft "Buy" after a 19% stock decline and improved valuation. UFPI's fundamentals have weakened due to industry headwinds, with revenue, profits, and cash flows all down across segments. Despite near-term challenges, UFPI's strong balance sheet and cheap valuation versus peers position it well for a future rebound.

Bath & Body Works, Inc. ( BBWI ) Q3 2026 Earnings Call November 20, 2025 8:30 AM EST Company Participants Luke Long Daniel Heaf - CEO & Director Eva Boratto - Chief Financial Officer Conference Call Participants Irwin Boruchow - Wells Fargo Securities, LLC, Research Division Matthew Boss - JPMorgan Chase & Co, Research Division Lorraine Maikis - BofA Securities, Research Division Alexandra Straton - Morgan Stanley, Research Division Kelly Crago - Citigroup Inc., Research Division Mark Altschwager - Robert W. Baird & Co. Incorporated, Research Division Adrienne Yih-Tennant - Barclays Bank PLC, Research Division Jungwon Kim - TD Cowen, …

Real Matters Inc. ( REAL:CA ) Q4 2025 Earnings Call November 20, 2025 10:00 AM EST Company Participants Lyne Fisher - Vice President of Investor Relations & Corporate Communications Brian Lang - CEO & Director Rodrigo Pinto - Executive VP & CFO Conference Call Participants Stephen Machielsen - BMO Capital Markets Equity Research Robert Young - Canaccord Genuity Corp., Research Division Martin Toner - ATB Capital Markets Inc., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Q4 2025 Real Matters earnings conference call.

Maximus, Inc. ( MMS ) Q4 2025 Earnings Call November 20, 2025 9:00 AM EST Company Participants James Francis - Vice President of Investor Relations Bruce L. Caswell - President, CEO & Director David Mutryn - CFO & Treasurer Presentation Operator Greetings, and welcome to the Maximus Fiscal 2025 Fourth Quarter and Year-End Earnings Conference Call.

Nvidia CEO Jensen Huang says the company will “continue to be rigorous” in preventing chips from ending up in the wrong hands during an interview with Ed Ludlow on "The Asia Trade." Nvidia delivered a surprisingly strong revenue forecast, projecting sales about $65 billion in the January quarter.